Diana Huang | Manager-Investor Relations |
Zhilin Li | President and Chief Executive Officer and Interim Chief Financial Officer |
Sam Hsing | Corporate Vice President |
Ladies and gentlemen, thank you for standing by and welcome to the China Pharma Holdings’ Q2 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to Ms.